Seminars in Thrombosis and Hemostasis

Article	Citations
	89
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	55
	55
Redefining Fibrinolytic Insufficiency in Sepsis-Associated DIC	50
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	42
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	41
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	39
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	37
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	35
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	35
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	34
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	33
Monitoring haemostatic function during extracorporeal membrane oxygenation with point-of-care viscoelastic assays: a narrative review	33
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	32
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	32
Testing for Lupus Anticoagulants	29
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only	29
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications	26
Platelet Function Testing: Update and Future Directions	26
Fifty Years of Fibrinogen Structure and Function	25
Platelet Activation and Thrombosis in COVID-19	25
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review	25
Editorial Compilation—XIII	24
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	23
External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific	23

Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future	23
	21
The History of Rare Bleeding Disorders	21
Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies	21
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	21
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice	19
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	19
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	19
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgM	18
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase	18
Toward 50 Years of Seminars in Thrombosis and Hemostasis	18
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	18
Bleeding in Patients with Renal Impairment: A Current Perspective	18
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism	18
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	18
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	17
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	17
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	17
	16
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?	16
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management	16
	15
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	15
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data	14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale	14
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	14
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	14
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	14
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	14
Automation in Platelet Function Testing: Current Challenges and Future Directions	14
Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients	14
Machine Learning Prediction of Stress-Induced D-dimer Reactivity in Male Physicians with and without Burnout	14
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans	14
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer	14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review	14
2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards	14
Colchicine as a Modulator of Platelet Function: A Systematic Review	13
Physical Activity in People with Hemophilia	13
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis	13
	13
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls	13
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic	13
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency	13
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	12
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection	12
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	12
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis	12
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives	12
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities	12

Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	12
Venous Thromboembolism in Children: The Rivaroxaban Experience	12
Editorial Compilation XIV	12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	12
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	11
Bleeding Scoring Systems in Neonates: A Systematic Review	11
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia	11
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization	11
A Historical Perspective on the Reversal of Anticoagulants	11
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	11
Thrombin Generation Assays: What are the Current Clinical Applications?	11
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis	11
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions	11
	11
Acquired Hemostasis Disorders	11
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	11
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	11
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis	11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	11
Editorial Compilation—Part XVIII	11
Platelet Physiology	11
D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program	10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?	10
Precision Medicine in Rare Bleeding Disorders	10
Do we Have the Gut to Beat Thrombosis?	10
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass	10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	10
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	9
Hemostasis Testing in the Emergency Department: A Narrative Review	9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment	9
100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review	9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing	9
Von Willebrand Disease Type 2A: An Update	9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	9
The Role of Platelets in Atherosclerosis: A Historical Review	9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	9
	9
NETosis in Acute Thrombotic Disorders	9
Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series	9
Non-factor Therapies for Hemophilia: Achievements and Perspectives	9
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care	8
	8
Internal Quality Control in Hemostasis Assays	8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction	8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke	8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?	8
One Hundred Years of Congenital Fibrinogen Disorders	8
Crucial Stepping Stones in Platelet History	8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality	8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets	8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?	8
How Do Muscles Protect Joints in Hemophilia? Integrating Mechanical, Neural, and Endocrine Mechanisms	7
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives	7
The More Recent History of Hemophilia Treatment	7
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	7
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research	7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up	7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies	7
	7
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	7
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study	7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	7
Next-Generation Sequencing and Emerging Technologies*	7
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond	7
Evolution of Antiphospholipid Syndrome	7
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	7
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	7
Rebalanced hemostasis, bleeding and thrombosis in liver disease: a comprehensive review of pathophysiology, management and future perspectives	7
Monitoring Hemostatic Function during Cardiac Surgery with Point-of-Care Viscoelastic Assays: A Narrative Review	6
A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity	6
Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors	6
Clinical, Laboratory Aspects and Management of Factor X Deficiency	6

Thrombosis Risk Assessment in Myeloproliferative Neoplasm—Is There a Role for Viscoelastic Testing?	6
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients	6
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome	6
Platelet Function in Acute Kidney Injury: A Systematic Review and a Cohort Study	6
Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with In Situ Vena Cava Thrombo	6
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes	6
Congenital Bleeding Disorders and COVID-19—A Systematic Literature Review	6
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review	6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer	6
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency	6
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges	6
Impact of Viral Infections on the Hemostatic System	6
Platelets in Neonatal Sepsis: Beyond Clotting, From Silent Players to Immune Orchestrators	6
Unlocking the Potential of MicroRNA Expression: Biomarkers for Platelet Reactivity and Coronary Artery Disease	6
	6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation	6
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen	6
2023 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards	6
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience	6
Plasma Kallikrein as a Forgotten Clotting Factor	6
Laboratory Evaluation of Antithrombin, Protein C, and Protein S	6
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	5
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	5
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	5
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	5
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial	5
What Role Does Microthrombosis Play in Long COVID?	5
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	5
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications	5
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	5
A Critical Reappraisal of the Bleeding Time	5
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	5
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	5
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	5
Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature	5
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	5
Platelets: Physiology and Biochemistry	5
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	5
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	5
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	5
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	5
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	5
Red Blood Cells and Tranexamic Acid in the Inhibition of Fibrinolysis	5
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	5
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	5
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	5
Isolated Low von Willebrand Factor Collagen-Binding Activity in Patients with a Positive Bleeding Phenotype: Diagnostic Implications for Von Willebrand Disease	5
Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)—A Systematic Review	4
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	4
	4
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	4
Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report	4
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis	4
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	4
Antiphospholipid Antibodies in Mental Disorders	4
Editorial Compilation—XV	4
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	4
	4
	4
Prophylaxis of Venous Thromboembolism in Children: A Systematic Review	4
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	4
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	4
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study	4
Red Blood Cells are Critical for Hemostasis and Thrombosis	4
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	4
Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality	4
Editorial Compilation XII	4
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	4
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	4
Optimizing and Extending the Risk-Adapted Management of Acute Pulmonary Embolism beyond the Acute Phase: Progress in Pulmonary Embolism Research	4
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort Study	4
Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies	4
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	4
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male	4
Neutrophil-Mediated Effects on Hemostasis and Thrombosis: Unraveling Their Complex Interaction in Thrombotic Events	4
The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium	4
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	4
A Tragedy within a Tragedy: How the Inappropriate Request for D-dimer during the COVID-19 Pandemic Might Have Harmed So Many People	4
Hemostasis, Thrombosis, and Vascular Biology in Psychiatric Disorders	4
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure	4
	4
Inherited or Immunological Thrombocytopenia: The Complex Nature of Platelet Disorders in 22q11.2 Deletion Syndrome	3
Extracellular Vesicles Drive Coagulopathy Across Hematologic Cancers	3
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients	3
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications	3
Venous Thrombosis in Airborne Viral Infections: Is Coronavirus Disease 2019 now Any Different from Influenza?	3
Solid Phase Assays for Antiphospholipid Antibodies	3
From Field Study to Clinical Practice, a Personal Historical Experience Using the PFA-100 Analyzer for Platelet Function Testing	3
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation	3
Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey	3
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan	3